Letters to the Editor

Methotrexate cytarabine thiotepa rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience

Faculty of Medicine, University of Toronto
Faculty of Medicine, University of Toronto
Faculty of Medicine, University of Toronto; Division of Medical Oncology and Hematology, St. Michael’s Hospital
AbbVie, Inc., North Chicago, IL
Faculty of Medicine, University of Toronto; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre
Faculty of Medicine, University of Toronto; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre
Faculty of Medicine, University of Toronto; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre
Faculty of Medicine, University of Toronto; Sunnybrook Health Sciences Centre, Odette Cancer Centre
Haematologica Early view Dec 1, 2022 https://doi.org/10.3324/haematol.2022.282014